Buy Brand name Cometriq from Europe in the same pack size presentation as the USA at almost 50% discount.
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name Cometriq originating from Europe is manufactured at the following site(s):Catalent Germany Schorndorf GmbH Steinbeisstr. 1 und 2 73614 Schorndorf GermanyTjoapack Netherlands B.V. Nieuwe Donk 9 4879 AC Etten-Leur The Netherlands
Information about Cometriq (Cabozantinib)
Cometriq is a targeted therapy medication used primarily in the treatment of certain types of cancer. Its active ingredient, cabozantinib, is a tyrosine kinase inhibitor that works by blocking multiple pathways involved in tumor growth and spread. It is specifically designed to interfere with the signaling pathways that cancer cells use to grow and metastasize.
Product Highlights
- Approved for the treatment of advanced or metastatic medullary thyroid cancer.
- It may also be used in the treatment of other cancers, such as renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC), under different brand names or formulations (e.g., Cabometyx for RCC and HCC).
Key Ingredient
Key Benefits
- Targets multiple pathways involved in cancer growth, which can help slow down or stop tumor progression.
- Can lead to shrinkage of tumors and potentially improve symptoms related to cancer.
- Helps in reducing the spread of cancer to other parts of the body.
Direction of Use
- Generally, one tablet should be taken orally once daily, with or without food.
- To achieve the best results, take the medication at the same time every day. Swallow the tablets whole and avoid crushing, chewing, or breaking them.
- Regular monitoring by your healthcare provider is essential to adjust the dose if needed and to check for side effects.
Safety Concerns
- May include fatigue, diarrhea, nausea, decreased appetite, and weight loss.
- Can include liver toxicity, gastrointestinal perforation, bleeding, high blood pressure, and kidney problems.
- Regular blood tests and liver function tests are needed to monitor for potential side effects and adjust dosage if necessary.
Avoid Cometriq (Cabozantinib) If
- You have a known allergy to cabozantinib or any component of the tablet.
- It may not be suitable if you have severe liver impairment, as it can exacerbate liver problems.
- The medication may be harmful to an unborn baby or nursing infant. Effective contraception should be used, and it’s important to discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
- Inform your healthcare provider about all other medications you are taking, as cabozantinib can interact with other drugs, potentially leading to increased side effects or reduced efficacy.
